134 related articles for article (PubMed ID: 8791997)
21. Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
J Cancer Res Clin Oncol; 1994; 120(7):409-14. PubMed ID: 8188734
[TBL] [Abstract][Full Text] [Related]
22. Antitumor activity of platinum(II) complexes of 1,2-diamino-cyclohexane isomers.
Kidani Y; Noji M; Tashiro T
Gan; 1980 Oct; 71(5):637-43. PubMed ID: 7227714
[TBL] [Abstract][Full Text] [Related]
23. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data.
Tashiro T; Kawada Y; Sakurai Y; Kidani Y
Biomed Pharmacother; 1989; 43(4):251-60. PubMed ID: 2790145
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl amines.
Anderson WK; Kasliwal R; Houston DM; Wang YS; Narayanan VL; Haugwitz RD; Plowman J
J Med Chem; 1995 Sep; 38(19):3789-97. PubMed ID: 7562909
[TBL] [Abstract][Full Text] [Related]
26. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.
Hacker MP; Khokhar AR; Brown DB; McCormack JJ; Krakoff IH
Cancer Res; 1985 Oct; 45(10):4748-53. PubMed ID: 4040806
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2].
Shamsuddin S; Santillan CC; Stark JL; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 1998 Aug; 71(1-2):29-35. PubMed ID: 9755489
[TBL] [Abstract][Full Text] [Related]
28. Antitumor platinum(II) complexes of N-monoalkyl-1R, 2R-diaminocyclohexane derivatives with alkyl groups as hindrance.
Sun Y; Yin R; Gou S; Zhaojian
J Inorg Biochem; 2012 Jul; 112():68-76. PubMed ID: 22561544
[TBL] [Abstract][Full Text] [Related]
29. Intraliposomal conversion of lipophilic cis-bis-carboxylato-trans-R,R-1,2-diaminocyclohexane-platinum (II) complexes into cis-bis-dichloro-trans-R,R-1,2-diaminocyclohexane-platinum (II).
Han I; Khokhar AR; Perez-Soler R
Cancer Chemother Pharmacol; 1996; 39(1-2):17-24. PubMed ID: 8995495
[TBL] [Abstract][Full Text] [Related]
30. [Comparative studies of antitumor activities of oxalate (1R, 2R-cyclohexanediammine) platinum (II) and cis-dichlorodiammine-platinum (II) using ovarian cancer transplanted into nude mice].
Suzumori K; Yasui Y; Asai H; Yagami Y
Gan To Kagaku Ryoho; 1986 Feb; 13(2):280-5. PubMed ID: 3947107
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antitumor activity of a series of (aminoethylpyrrolidine) platinum complexes.
Khokhar AR; Brown DB; McCormack JJ; Hacker MP
Cancer Chemother Pharmacol; 1989; 23(1):15-8. PubMed ID: 2909285
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization and antitumor activity of novel octahedral Pt(IV) complexes.
Kwon YE; Whang KJ; Park YJ; Kim KH
Bioorg Med Chem; 2003 Apr; 11(8):1669-76. PubMed ID: 12659753
[TBL] [Abstract][Full Text] [Related]
33. Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action.
Li H; Gao X; Liu R; Wang Y; Zhang M; Fu Z; Mi Y; Wang Y; Yao Z; Gao Q
Eur J Med Chem; 2015 Aug; 101():400-8. PubMed ID: 26177447
[TBL] [Abstract][Full Text] [Related]
34. Toxicity and efficacy studies on a series of lipid-soluble dineodecanoato(trans-R,R- and trans-S,S-1,2-diaminocyclohexane) platinum (II) complexes entrapped in liposomes.
Khokhar AR; al-Baker S; Perez-Soler R
Anticancer Drugs; 1992 Apr; 3(2):95-100. PubMed ID: 1525398
[TBL] [Abstract][Full Text] [Related]
35. Characterization of monoclonal antibodies against (1R,2R)-cyclohexanediamine platinum(II)-DNA adduct.
Hirose J; Inoue K; Morimoto E; Iwamoto H; Yamaguti Y; Kitase M; Inagaki K; Hiromi K
Biol Pharm Bull; 1996 Sep; 19(9):1220-2. PubMed ID: 8889045
[TBL] [Abstract][Full Text] [Related]
36. Coordination modes vs. antitumor activity: synthesis and antitumor activity of novel platinum(II) complexes of N-substituted amino dicarboxylic acids.
Kim YS; Song R; Chung HC; Jun MJ; Sohn YS
J Inorg Biochem; 2004 Jan; 98(1):98-104. PubMed ID: 14659638
[TBL] [Abstract][Full Text] [Related]
37. {(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivo.
Abramkin SA; Jungwirth U; Valiahdi SM; Dworak C; Habala L; Meelich K; Berger W; Jakupec MA; Hartinger CG; Nazarov AA; Galanski MS; Keppler BK
J Med Chem; 2010 Oct; 53(20):7356-64. PubMed ID: 20886814
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes.
Hrubisko M; Balázová E; Kiss F; Kovácová J; Ujházy V
Neoplasma; 1989; 36(6):651-7. PubMed ID: 2615869
[TBL] [Abstract][Full Text] [Related]
39. Differential antitumor activity and toxicity of isomeric 1,2-diaminocyclohexane platinum (II) complexes.
Siddik ZH; al-Baker S; Burditt TL; Khokhar AR
J Cancer Res Clin Oncol; 1993; 120(1-2):12-6. PubMed ID: 8270602
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
